Clinical study to evaluate the safety of investigational medicinal product called AD-O51.4 in patients with advanced malignancies
ADO-01-24
Phase 1 other active
Quick answer
Clinical study to evaluate the safety of investigational medicinal product called AD-O51.4 in patients with advanced malignancies for Patients suffering from cancer without further treatment options. is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Patients suffering from cancer without further treatment options.
- Phase
- Phase 1
- Modality
- other
- Status
- active